Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.

Wang, Hui-Jing; Gu, Han-Xin; Eijkelkamp, Niels; Heijnen, Cobi J; Kavelaars, Annemieke

Wang, Hui-Jing; Gu, Han-Xin; Eijkelkamp, Niels; Heijnen, Cobi J; Kavelaars, Annemieke.

Afiliação

Wang HJ; Laboratory of Neuropsychopharmacology, College of Fundamental Medicine, Shanghai University of Medicine & Health Science, Shanghai, China.
Gu HX; Laboratory of Neuroimmunology and Developmental Origins of Disease, University Medical Center Utrecht, Utrecht, Netherlands.
Eijkelkamp N; Laboratory of Neuropsychopharmacology, College of Fundamental Medicine, Shanghai University of Medicine & Health Science, Shanghai, China.
Heijnen CJ; Laboratory of Neuroimmunology and Developmental Origins of Disease, University Medical Center Utrecht, Utrecht, Netherlands.
Kavelaars A; Division of Internal Medicine, Laboratory of Neuroimmunology, Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Front Pharmacol ; 9: 592, 2018.

Article em En | MEDLINE | ID: mdl-29922165

Palavras-chave

ESI-09; Epac; GDNF; GRK2; HSV vector; hyperalgesic priming

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google